STTK logo

Shattuck Labs (STTK)

Profile

Full Name

Shattuck Labs, Inc.

Ticker Symbol

STTK

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 9, 2020

Indexes

Not included

Website

http://www.shattucklabs.com

Employees

44

Key Details

Price

$0.76(-7.93%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$5.72M(+245.26% YoY)

Annual EPS

-$1.49(+27.32% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.76
STTK price is $0.76

30-Day Relative Volume

0.38
STTK 30-day relative volume is 0.38

Price Performance

Price Most recent change

-7.93%
STTK price was down -7.93% on Apr 16, 2025

Price YTD change

-37.6%
STTK price is down -37.6% since January 1st

Price 1-year change

-92.47%
STTK price is down -92.47% year-on-year

Price 3-year change

-79.76%
STTK price is down -79.76% over the past 3 years

Price Range

Price All-time high

$60.52
STTK price is currently -98.75% below its historical high of $60.52

Price 3-year low

$0.69
STTK price is currently +9.10% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$36.16M
STTK market capitalization is $36.16 million

Market cap 3-year change

-77.12%
STTK market capitalization is down -77.12% over the past 3 years

Market cap All-time high

$2.40B
STTK market capitalization is currently -98.50% below its historical high of $2.40 billion

Market cap sector rank

33.72%
STTK market capitalization is higher than 33.72% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.73%
STTK shares outstanding is up +0.73% year-on-year

Shares Outstanding 3-Year Change

+13.03%
STTK shares outstanding is up +13.03% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.32
STTK beta is 1.32

200-day SMA

$2.01
STTK price is currently -62.49% below its 200-day simple moving average

50-day SMA

$1.17
STTK price is currently -35.33% below its 50-day simple moving average

RSI

40.12
STTK 14-day relative strength index is 40.12

Volume

0.38
STTK 30-day relative volume is 0.38

ATR

$0.14
STTK average true range is $0.14

10-day Historical Volatility

457.52%
STTK 10-day historical volatility is 457.52%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$5.72M
STTK annual revenue is $5.72 million

Revenue Analysts estimate

-
STTK annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+245.26%
STTK annual revenue is up +245.26% year-on-year

Revenue Sector rank

22.4%
STTK annual revenue is higher than 22.4% of companies in Healthcare sector

EPS

EPS

-$1.49
STTK annual earnings per share is -$1.49

EPS Analysts estimate

-$1.09
STTK annual earnings per share is currently +36.77% higher than the consensus analysts' forecast

EPS 1-year change

+27.32%
STTK annual earnings per share is up +27.32% year-on-year

EPS Sector rank

45.87%
STTK annual earnings per share is higher than 45.87% of companies in Healthcare sector

Profit

Gross profit

-
STTK annual gross profit value is unknown

Gross margin

-
STTK annual gross profit margin value is unknown

Operating profit

-$80.57M
STTK annual operating income is -$80.57 million

Operating margin

-1408.27%
STTK annual operating profit margin is -1408.27%

Net income

-$75.41M
STTK annual net profit is -$75.41 million

Net margin

-1318.13%
STTK annual net profit margin is -1318.13%

Expenses

Total expenses

$86.29M
STTK annual total expenses is $86.29 million

Operating expenses

$86.29M
STTK annual total operating expenses is $86.29 million

Cost of goods sold

-
STTK annual cost of goods sold value is unknown

Selling, general & administrative expenses

$19.08M
STTK annual SGA is $19.08 million

Depreciation and amortization

$3.83M
STTK annual depreciation & amortization is $3.83 million

Interest expense

-
STTK annual interest expense value is unknown

Income tax

-
STTK annual income tax value is unknown

EBIT & EBITDA

EBIT

-$80.57M
STTK annual earnings before interest & taxes is -$80.57 million

EBITDA

-$76.74M
STTK annual EBITDA is -$76.74 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$91.05M
STTK annual total assets is $91.05 million

Non current assets

$11.83M
STTK annual long term assets is $11.83 million

Current assets

$79.22M
STTK annual total current assets is $79.22 million

Cash and cash equivalents

$57.39M
STTK annual cash & cash equivalents is $57.39 million

Accounts receivable

-
STTK annual accounts receivable value is unknown

Inventory

-
STTK annual inventory value is unknown

Liabilities

Total liabilities

$11.42M
STTK annual total liabilities is $11.42 million

Long term liabilities

$2.51M
STTK annual total long term liabilities is $2.51 million

Current liabilities

$8.92M
STTK annual total current liabilities is $8.92 million

Accounts payable

$2.42M
STTK annual accounts payable is $2.42 million

Debt

Total debt

$3.41M
STTK annual total debt is $3.41 million

Total debt 1-year change

-18.94%
STTK annual total debt is down -18.94% year-on-year

Long term debt

$2.51M
STTK annual long term debt is $2.51 million

Short term debt

$900.00K
STTK annual short term debt is $900.00 thousand

Equity & Capital

Shareholders equity

$79.63M
STTK annual stockholders equity is $79.63 million

Book value

$79.63M
STTK annual book value is $79.63 million

Retained earnings

-$381.72M
STTK annual retained earnings is -$381.72 million

Working capital

$70.30M
STTK annual working capital is $70.30 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$60.52M
STTK annual cash flow from operations is -$60.52 million

Cash from operations 1-year change

+25.5%
STTK annual cash flow from operations is up +25.5% year-on-year

Cash from investing

-$8.51M
STTK annual cash flow from investing activities is -$8.51 million

Cash from investing 1-year change

-107.68%
STTK annual cash flow from investing activities is down -107.68% year-on-year

Cash from financing

$787.00K
STTK annual cash flow from financing activities is $787.00 thousand

Cash from financing 1-year change

-98.38%
STTK annual cash flow from financing activities is down -98.38% year-on-year

CAPEX

CAPEX

$59.00K
STTK annual capital expenditures is $59.00 thousand

CAPEX 1-year change

-85.5%
STTK annual capital expenditures is down -85.5% year-on-year

Free Cash Flow

Free cash flow

-$60.57M
STTK annual free cash flow is -$60.57 million

Free cash flow 1-year change

+25.8%
STTK annual free cash flow is up +25.8% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
STTK annual gross profit margin value is unknown

Operating margin

-1408.27%
STTK annual operating profit margin is -1408.27%

Net margin

-1318.13%
STTK annual net profit margin is -1318.13%

ROA & ROE

ROA

-60.18%
STTK annual return on assets is -60.18%

ROE

-67.23%
STTK annual return on equity is -67.23%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
STTK price to earnings ratio value is unknown

PE ratio Sector rank

-
STTK price to earnings ratio is unknown

PB Ratio

PB ratio

0.45
STTK price to book ratio is 0.45

PB ratio Sector rank

28.42%
STTK price to book ratio is higher than 28.42% of companies in Healthcare sector

PS Ratio

PS ratio

-
STTK price to sales ratio value is unknown

PS ratio Sector rank

-
STTK price to sales ratio is unknown

Enterprise value

Enterprise value

-$17.82M
STTK enterprise value is -$17.82 million

Enterprise value Sector rank

3.3%
STTK enterprise value is higher than 3.3% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.23
STTK EV/EBITDA is 0.23

EV/EBITDA Sector rank

69.3%
STTK EV/EBITDA is higher than 69.3% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

8.88
STTK annual current ratio is 8.88

Quick ratio

-
STTK annual quick ratio value is unknown

Leverage

Debt to equity

0.00
STTK annual debt to equity ratio is 0.00

Interest coverage ratio

-
STTK annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
STTK piotroski f-score value is unknown

Altman Z-Score

-5.90
STTK altman z-score is -5.90

Analyst ratings

Recent major analysts updates

Mar 27, 25 Needham
Hold
Mar 27, 25 HC Wainwright & Co.
Neutral
Mar 17, 25 Leerink Partners
Outperform
Nov 15, 24 HC Wainwright & Co.
Neutral
Nov 14, 24 Needham
Hold
Oct 2, 24 Needham
Hold
Oct 2, 24 Citigroup
Neutral
Oct 1, 24 HC Wainwright & Co.
Neutral
Aug 27, 24 HC Wainwright & Co.
Buy
Aug 15, 24 Citigroup
Buy

Institutional Ownership

Similar stocks

Rein Therapeutics (RNTX)
ITRM logo
Iterum Therapeutics (ITRM)
SCYX logo
SCYNEXIS (SCYX)
CELU logo
Celularity (CELU)
APLT logo
Applied Therapeutics (APLT)
DXR logo
Daxor (DXR)
APYX logo
Apyx Medical (APYX)
KPTI logo
Karyopharm Therapeutics (KPTI)
RMTI logo
Rockwell Medical (RMTI)
  • What is the ticker symbol for Shattuck Labs?
  • Does Shattuck Labs pay dividends?
  • What sector is Shattuck Labs in?
  • What industry is Shattuck Labs in?
  • What country is Shattuck Labs based in?
  • When did Shattuck Labs go public?
  • Is Shattuck Labs in the S&P 500?
  • Is Shattuck Labs in the NASDAQ 100?
  • Is Shattuck Labs in the Dow Jones?
  • When was Shattuck Labs's last earnings report?
  • When does Shattuck Labs report earnings?
  • Should I buy Shattuck Labs stock now?

What is the ticker symbol for Shattuck Labs?

The ticker symbol for Shattuck Labs is NASDAQ:STTK

Does Shattuck Labs pay dividends?

No, Shattuck Labs does not pay dividends

What sector is Shattuck Labs in?

Shattuck Labs is in the Healthcare sector

What industry is Shattuck Labs in?

Shattuck Labs is in the Biotechnology industry

What country is Shattuck Labs based in?

Shattuck Labs is headquartered in United States

When did Shattuck Labs go public?

Shattuck Labs's initial public offering (IPO) was on October 9, 2020

Is Shattuck Labs in the S&P 500?

No, Shattuck Labs is not included in the S&P 500 index

Is Shattuck Labs in the NASDAQ 100?

No, Shattuck Labs is not included in the NASDAQ 100 index

Is Shattuck Labs in the Dow Jones?

No, Shattuck Labs is not included in the Dow Jones index

When was Shattuck Labs's last earnings report?

Shattuck Labs's most recent earnings report was on Mar 27, 2025

When does Shattuck Labs report earnings?

The next expected earnings date for Shattuck Labs is May 2, 2025

Should I buy Shattuck Labs stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page